Official reprint from UpToDate®
www.uptodate.com ©2016 UpToDate®

Risk of infection in children with fever and non-chemotherapy-induced neutropenia

Nabil M Ahmed, MD, MPH
Debra L Palazzi, MD, MEd
Section Editors
Morven S Edwards, MD
Donald H Mahoney, Jr, MD
Deputy Editor
Mary M Torchia, MD


Fever may be the first manifestation of a life-threatening infection in the neutropenic child, particularly one with a primary hematologic disease such as severe aplastic anemia or congenital neutropenia. Because of important differences between hematology and oncology patients with neutropenia, the risk of infection in hematology patients with different types of non-chemotherapy-induced neutropenia and fever are reviewed here. The management of fever and neutropenia in these patients and in children with chemotherapy-induced neutropenia are discussed separately. (See "Evaluation and management of fever in children with non-chemotherapy-induced neutropenia" and "Fever in children with chemotherapy-induced neutropenia", section on 'Definitions'.)


Generally, neutropenia is defined as an absolute neutrophil count (ANC) <1500 cells/microL. The ANC is calculated using the following formula:

ANC = total white blood cell count (cells/microL) x (percent neutrophils + percent bands) ÷ 100

Recognizing that the definition of a normal ANC varies with age and race is important. The lower limit of normal for the ANC in infants between two weeks and six months of age is lower than that for the older child (1000/microL versus 1500/microL) [1]. Also, normal neutrophil values for people of African descent are lower than those for Caucasians [2].

The degree of neutropenia is classified as follows:


Subscribers log in here

To continue reading this article, you must log in with your personal, hospital, or group practice subscription. For more information or to purchase a personal subscription, click below on the option that best describes you:
Literature review current through: Sep 2016. | This topic last updated: May 4, 2016.
The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment. Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions. The use of this website is governed by the UpToDate Terms of Use ©2016 UpToDate, Inc.
  1. Dallman PR. Neutropenia. In: Pediatrics, Rudolph AM (Ed), Appleton-Century-Crofts, New York 1977. p.1178.
  2. Caramihai E, Karayalcin G, Aballi AJ, Lanzkowsky P. Leukocyte count differences in healthy white and black children 1 to 5 years of age. J Pediatr 1975; 86:252.
  3. Bodey GP, Buckley M, Sathe YS, Freireich EJ. Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia. Ann Intern Med 1966; 64:328.
  4. Jonsson OG, Buchanan GR. Chronic neutropenia during childhood. A 13-year experience in a single institution. Am J Dis Child 1991; 145:232.
  5. Alexandropoulou O, Kossiva L, Haliotis F, et al. Transient neutropenia in children with febrile illness and associated infectious agents: 2 years' follow-up. Eur J Pediatr 2013; 172:811.
  6. Husain EH, Mullah-Ali A, Al-Sharidah S, et al. Infectious etiologies of transient neutropenia in previously healthy children. Pediatr Infect Dis J 2012; 31:575.
  7. Karavanaki K, Polychronopoulou S, Giannaki M, et al. Transient and chronic neutropenias detected in children with different viral and bacterial infections. Acta Paediatr 2006; 95:565.
  8. Alario AJ, O'Shea JS. Risk of infectious complications in well-appearing children with transient neutropenia. Am J Dis Child 1989; 143:973.
  9. Serwint JR, Dias MM, Chang H, et al. Outcomes of febrile children presumed to be immunocompetent who present with leukopenia or neutropenia to an ambulatory setting. Clin Pediatr (Phila) 2005; 44:593.
  10. Barg AA, Kozer E, Mordish Y, et al. The Risk of Serious Bacterial Infection in Neutropenic Immunocompetent Febrile Children. J Pediatr Hematol Oncol 2015; 37:e347.
  11. Bux J, Behrens G, Jaeger G, Welte K. Diagnosis and clinical course of autoimmune neutropenia in infancy: analysis of 240 cases. Blood 1998; 91:181.
  12. Dale DC, Guerry D 4th, Wewerka JR, et al. Chronic neutropenia. Medicine (Baltimore) 1979; 58:128.
  13. Fioredda F, Calvillo M, Burlando O, et al. Infectious complications in children with severe congenital, autoimmune or idiopathic neutropenia: a retrospective study from the Italian Neutropenia Registry. Pediatr Infect Dis J 2013; 32:410.
  14. Dale DC, Hammond WP 4th. Cyclic neutropenia: a clinical review. Blood Rev 1988; 2:178.
  15. Hopkins DG, Kushner JP. Clostridial species in the pathogenesis of necrotizing enterocolitis in patients with neutropenia. Am J Hematol 1983; 14:289.
  16. Bar-Joseph G, Halberthal M, Sweed Y, et al. Clostridium septicum infection in children with cyclic neutropenia. J Pediatr 1997; 131:317.
  17. Weinberger M. Approach to management of fever and infection in patients with primary bone marrow failure and hemoglobinopathies. Hematol Oncol Clin North Am 1993; 7:865.
  18. Kostman R. Infantile genetic agranulocytosis. A review with presentation of ten new cases. Acta Paediatr Scand 1975; 64:362.
  19. Weinberger M, Elattar I, Marshall D, et al. Patterns of infection in patients with aplastic anemia and the emergence of Aspergillus as a major cause of death. Medicine (Baltimore) 1992; 71:24.
  20. Torres HA, Bodey GP, Rolston KV, et al. Infections in patients with aplastic anemia: experience at a tertiary care cancer center. Cancer 2003; 98:86.
  21. Quarello P, Saracco P, Giacchino M, et al. Epidemiology of infections in children with acquired aplastic anaemia: a retrospective multicenter study in Italy. Eur J Haematol 2012; 88:526.
  22. Bacigalupo A, Hows J, Gluckman E, et al. Bone marrow transplantation (BMT) versus immunosuppression for the treatment of severe aplastic anaemia (SAA): a report of the EBMT SAA working party. Br J Haematol 1988; 70:177.